Search Results

You searched for : elililly  

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ...
Nov 17

A Ray of Hope in Alzheimer's Research: Donanemab Shows Promise in Slowing Cognitive Decline

The findings not only represent a major breakthrough for Eli Lilly but also for the scientific community as a whole, proving that perseverance and dedication ...
Jul 18

Lilly Announces Acquisition of Protomer Technologies

Pharma merger and acquisitions...
Jul 15

Eli Lilly and MiNA Therapeutics Announce saRNA Research Collaboration

MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly's key therapeutic ...
May 15

US government stops distribution of Eli Lilly Covid-19 antibody treatment for Covid-19

The move comes after the detection of different Covid variants ...
Mar 26

Eli Lilly announces agreement to acquire Prevail Therapeutics

The acquisition will establish a new modality for drug discovery and development at Lilly ...
Dec 15

AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19

Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020...
Nov 23

Eli Lilly collaborates with Precision BioSciences for genome editing research

This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges...
Nov 21

Eli Lilly's bamlanivimab receives US FDA clearance for the treatment of COVID-19

Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19...
Nov 12

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD....
Nov 06

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric cancer

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ...
Oct 28

Eli Lilly announces agreement to acquire Disarm Therapeutics

Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition...
Oct 16

J & J and Eli Lilly halts Covid-19 drug trial

ELI Lilly, J & J and AstraZeneca halts covid drug trials...
Oct 15

Innovent and Eli Lilly announce the NMPA granted marketing approval for HALPRYZA in China

The survival rate is also relatively higher than other tumour types when having appropriate treatment...
Oct 09

Verzinio from Eli Lilly cuts recurrence from Breast Cancer by 25%

Drug combo cuts recurrence risk of breast cancer by 25%...
Sep 21

Anti-inflammatory drug like Baricitinib may shorten Covid-19 recovery time ; Eli Lilly

Eli Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalized Covid-19 patients. ...
Sep 15

Lilly initiates phase 3 trial of LY-CoV555 for prevention of COVID-19

More than 40 percent of coronavirus deaths in the U.S. linked to long-term care facilities;...
Aug 03

ELI LILLY begins 3rd phase clinical trial with Baricitinib for COVID patients

ELI Lilly close to coronavirus antiviral as 3rd phase trial begins...
Jun 17

ELI Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment

This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly and AbCellera ...
Jun 06

AbCellera and Eli Lilly Agreed to Co-develop Antibody Products to Fight COVID-19

AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create ...
Mar 13

Eli Lilly Announced the Successful Completion of its Acquisition of Dermira, Inc.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. With this ...
Feb 22

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ...
Sep 20

22 Matching result(s) found!


Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023